Ascletis Pharma Inc (2VJ) — Working Capital to Net Assets Ratio
Ascletis Pharma Inc (2VJ) has a Working Capital to Net Assets ratio of 92.7% as of December 2025. Working capital of €1.79 Billion (current assets of €1.92 Billion minus current liabilities of €127.59 Million) is measured against net assets of €1.93 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Ascletis Pharma Inc balance sheet quality to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Ascletis Pharma Inc Working Capital to Net Assets (2016–2025)
This chart shows how Ascletis Pharma Inc's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2016 to 2025. As of December 2025, the ratio stands at 92.7%, reflecting working capital of €1.79 Billion against net assets of €1.93 Billion EUR. Check Ascletis Pharma Inc (2VJ) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Ascletis Pharma Inc (2016–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Ascletis Pharma Inc from 2016 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market cap of Ascletis Pharma Inc.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 92.7% | €1.79 Billion | €1.93 Billion | €1.92 Billion | €127.59 Million | ▲ +0.3 pp |
| 2024 | 92.5% | €1.82 Billion | €1.97 Billion | €1.97 Billion | €153.05 Million | ▼ -1.1 pp |
| 2023 | 93.6% | €2.19 Billion | €2.34 Billion | €2.33 Billion | €140.68 Million | ▼ -2.3 pp |
| 2022 | 95.9% | €2.44 Billion | €2.54 Billion | €2.54 Billion | €108.19 Million | ▲ +2.8 pp |
| 2021 | 93.1% | €2.54 Billion | €2.73 Billion | €2.63 Billion | €90.97 Million | ▲ +0.7 pp |
| 2020 | 92.4% | €2.76 Billion | €2.98 Billion | €2.83 Billion | €73.77 Million | ▼ -1.0 pp |
| 2019 | 93.4% | €3.10 Billion | €3.32 Billion | €3.19 Billion | €87.65 Million | ▼ -2.0 pp |
| 2018 | 95.4% | €3.27 Billion | €3.43 Billion | €3.36 Billion | €93.41 Million | ▲ +6.1 pp |
| 2017 | 89.3% | €776.39 Million | €869.83 Million | €875.62 Million | €99.23 Million | ▼ -6.7 pp |
| 2016 | 96.0% | €392.61 Million | €409.08 Million | €466.01 Million | €73.40 Million | — |